文献速递毛发、甲与色素性疾病

ERAP1与4个MHC I类等位基因在额部纤维性脱发中的上位效应:全基因组关联研究荟萃分析

Epistasis of ERAP1 With 4 Major Histocompatibility Complex Class I Alleles in Frontal Fibrosing Alopecia: A Genome-Wide Association Study Meta-Analysis.
PubMed 文献 · JAMA Dermatol · 2025-01-01

该研究合并4项全基因组关联研究,纳入1585例欧洲女性额部纤维性脱发(FFA)患者和5083例对照,采用SE加权荟萃分析。发现5q15处ERAP1的rs10045403与FFA易感相关(OR 1.30,95%CI 1.19-1.43,P=3.6×10⁻⁸),且MHC内HLA-A*11:01、HLA-A*33:01、HLA-B*07:02和HLA-B*35:01独立关联。ERAP1变异对FFA风险的影响仅见于携带至少1个MHC I类风险等位基因的个体,提示上位效应。

要点

  • ERAP1 rs10045403与FFA易感独立相关,OR 1.30。
  • HLA-A*11:01、A*33:01、B*07:02、B*35:01为独立风险等位基因。
  • ERAP1风险效应仅存在于携带MHC I类风险等位基因者。

核心结论

  • ERAP1与MHC I类等位基因之间存在超加性上位效应,共同影响FFA易感性。

研究设计与样本

  • 4项全基因组关联研究的SE加权荟萃分析,纳入1585例欧洲女性FFA患者和5083例对照。
  • 在MHC区域进行逐步条件分析以确定独立关联的经典MHC I类等位基因。
  • 对MHC和ERAP1风险等位基因进行统计交互检验。

主要发现

  • 全基因组显著关联见于4个位点,包括5q15处新易感位点,可精细定位至ERAP1 5'非翻译区rs10045403。
  • rs10045403与FFA关联:OR 1.30,95%CI 1.19-1.43,P=3.6×10⁻⁸。
  • MHC内FFA风险与HLA-A*11:01、HLA-A*33:01、HLA-B*07:02和HLA-B*35:01独立相关。
  • ERAP1位点变异对FFA风险的影响仅见于携带至少1个MHC I类风险等位基因的个体。

临床怎么用

  • 提示ERAP介导的抗原加工呈递通路可能为FFA的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Frontal fibrosing alopecia (FFA) is an inflammatory and scarring form of hair loss of increasing prevalence that most commonly affects women. An improved understanding of the genetic basis of FFA will support the identification of pathogenic mechanisms and therapeutic targets. OBJECTIVE: To identify novel genomic loci at which common genetic variation affects FFA susceptibility and assess nonadditive effects on genetic risk between susceptibility loci. DESIGN, SETTING, AND PARTICIPANTS: Four genome-wide association studies were combined using an SE-weighted meta-analysis. Within the major histocompatibility complex (MHC) locus, stepwise conditional analysis was undertaken to determine independently associated classical MHC class I alleles. Statistical tests for epistatic interaction were performed between risk alleles at the MHC and endoplasmic reticulum aminopeptidase 1 (ERAP1) loci. MAIN OUTCOMES AND MEASURES: Genome-wide significant locus associated with FFA and nonadditive effects on genetic risk between susceptibility loci. RESULTS: Of 6668 included patients, there were 1585 European female individuals with FFA and 5083 controls. Genome-wide significant associations were identified at 4 genomic loci, including a novel susceptibility locus at 5q15, and the association signal could be fine-mapped to a single nucleotide substitution (rs10045403) in the 5' untranslated region of ERAP1 (rs10045403; odds ratio, 1.30; 95% CI, 1.19-1.43; P = 3.6 × 10-8). Within the MHC, FFA risk was statistically independently associated with HLA-A*11:01, HLA-A*33:01, HLA-B*07:02, and HLA-B*35:01. FFA risk was affected by genetic variation at the ERAP1 locus only in individuals who carried at least 1 of the MHC class I risk alleles. CONCLUSIONS AND RELEVANCE: In this genome-wide meta-analysis, a supra-additive effect of genetic variation was found that affected peptide trimming and antigen presentation on FFA susceptibility. Patients with FFA may benefit from emerging therapeutic approaches that modulate ERAP-mediated processes.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Rayinda T, Dand N, McSweeney SM, et al. Epistasis of ERAP1 With 4 Major Histocompatibility Complex Class I Alleles in Frontal Fibrosing Alopecia: A Genome-Wide Association Study Meta-Analysis. JAMA Dermatol. 2025. PMID: 39937552. doi:10.1001/jamadermatol.2024.6434

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。